Santen Pharmaceutical Co Ltd
TSE:4536
Santen Pharmaceutical Co Ltd
Income to Minority Interest
Santen Pharmaceutical Co Ltd
Income to Minority Interest Peer Comparison
Competitive Income to Minority Interest Analysis
Latest Figures & CAGR of Competitors
Company | Income to Minority Interest | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Santen Pharmaceutical Co Ltd
TSE:4536
|
Income to Minority Interest
-¥60m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Income to Minority Interest
-¥130m
|
CAGR 3-Years
8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
27%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Income to Minority Interest
-¥285m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-88%
|
CAGR 10-Years
N/A
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Income to Minority Interest
-¥4.2B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-10%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Income to Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Astellas Pharma Inc
TSE:4503
|
Income to Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Santen Pharmaceutical Co Ltd's Income to Minority Interest?
Income to Minority Interest
-60m
JPY
Based on the financial report for Mar 31, 2024, Santen Pharmaceutical Co Ltd's Income to Minority Interest amounts to -60m JPY.